Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cumulative Irritation Potential of ZuraPrep
NCT02160574Phase 1Completed
- Sponsor
- Zurex Pharma
- Start
- Jun 2014
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, single-blind, single-arm trial of ChloraPrep in surgical site infection (SSI), sponsored by Zurex Pharma. Primary endpoint: Visual Evaluation of Skin Condition. Started Jun 2014; status: completed.
02
Drugs
ChloraPrep
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02160574.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02160574.